Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Pitts

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Therapeutic Innovation & Regulatory Science|September 21, 2018
Using Off-Label Communications to Responsibly Advance the Public HealthPeter J Pitts
The Patient|September 2, 2016
The Patient Voice: At the Intersection of a US Regulatory RevolutionPeter J Pitts
Nature Biotechnology|July 11, 2007
Settling for second best?Peter J Pitts
The Patient|September 19, 2022
Regulating Between the Notes: The US FDA and the Evolution of the Patient Voice Through Twenty-First Century Regulatory SciencePeter J Pitts
Pharmaceutical Medicine|January 24, 2024
Female Problems: Women's Health Mustn't be Ghettoized in the UterusPeter J Pitts
Nature Biotechnology|June 20, 2020
Regulatory centaursPeter J Pitts
Health Affairs (Project Hope)|September 29, 2004
Turning point or tipping point: new FDA draft guidances and the future of DTC advertisingPeter J Pitts
Therapeutic Innovation & Regulatory Science|September 18, 2018
openFDA: An Open QuestionPeter J Pitts
The Patient|June 6, 2019
Towards Meaningful Engagement for the Patient VoicePeter J Pitts
The Patient|April 18, 2020
Our Most Powerful Weapon to Fight COVID-19: Patient InvolvementPeter J Pitts
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Therapeutic Innovation & Regulatory Science|September 21, 2018
Using Off-Label Communications to Responsibly Advance the Public HealthPeter J Pitts
The Patient|September 2, 2016
The Patient Voice: At the Intersection of a US Regulatory RevolutionPeter J Pitts
Nature Biotechnology|July 11, 2007
Settling for second best?Peter J Pitts
The Patient|September 19, 2022
Regulating Between the Notes: The US FDA and the Evolution of the Patient Voice Through Twenty-First Century Regulatory SciencePeter J Pitts
Pharmaceutical Medicine|January 24, 2024
Female Problems: Women's Health Mustn't be Ghettoized in the UterusPeter J Pitts
Nature Biotechnology|June 20, 2020
Regulatory centaursPeter J Pitts
Health Affairs (Project Hope)|September 29, 2004
Turning point or tipping point: new FDA draft guidances and the future of DTC advertisingPeter J Pitts
Therapeutic Innovation & Regulatory Science|September 18, 2018
openFDA: An Open QuestionPeter J Pitts
The Patient|June 6, 2019
Towards Meaningful Engagement for the Patient VoicePeter J Pitts
The Patient|April 18, 2020
Our Most Powerful Weapon to Fight COVID-19: Patient InvolvementPeter J Pitts
Pageof 4